Monday

Innovation in action: moving forward with basal insulins in people with T2D

Understanding and Preventing Hypoglycemia in Diabetes

CGM as an Essential Companion Across Diabetes Management

People, Populations and Practice: Exploring the Journey across Diabetes care

Turning the tide: How can diabetologists make waves in weight management?

Emerging therapies in heart and kidney disease: Effects and clinical implications of finerenone

The three Gs in the context of gut hormone multiagonism

Thinking together: learnings from 3-real life cases to improve diabetes management and transform your clinical practice with CGM

The Kidney in Focus in Diabetes Care – Novel Strategies for Changing CKD Trajectory

Increasing the Tempo: Early initiation of SGLT2is for cardiorenal protection

Expanding Horizons in Insulin Therapy: Applications of MiniMed™ 780G system and MDI solutions

Prepare, Prevent & Act: Unlocking the power of prediction for advanced in-time glycaemic control

The glucagon philharmonic: Orchestrating metabolic harmony in obesity, liver disease and health

The Heart in Focus in Obesity Care – Lowering the CV Burden with Novel Weight Loss Therapies

Exploring therapeutic mechanisms to improve organ function in CVRM diseases

iCan real-time CGM system: An option for all patient groups

Redefining T2D and Obesity Management: The First and Only Approved GIP and GLP-1 Receptor Agonist

Why Act? Expert Insights on the Value of Protection Against Vaccine-Preventable Disease in Patients with Diabetes

Triple protection of SGLT2i: ACT2DAY for patients’ future

Tuesday

AI-assisted screening for diabetic retinopathy – real-life outcomes

Beta-cell dysfunction in T2D – is it irrevocable?

Partner together to turn small steps into big wins

Strengthening diagnosis and treatment of CKD in Type 1 Diabetes: current and future perspectives

The right time for Metformin

Improving adherence, glycemic control and outcomes for people living with diabetes

At the crossroads of specialties: Exploring the trends in the holistic, person-centred approach in cardiovascular-kidney-metabolic disease

Wednesday

Conversations between specialties: the importance of SGLT2 inhibitor initiation for the interdisciplinary management of cardio, renal and metabolic conditions

The Omnipod® 5 Era: Celebrating Success Through Transformational Person-Centered AID Care

Powering up progress: How CGM insights are revolutionizing Type 2 diabetes care

A New Technological Horizon: Optimizing Treatment with Tandem Diabetes Care

T2D care in the digital era: ​evidence with once-weekly insulins, CGM and other digital health tools​

Tackling clinical inertia in Type 2 diabetes with Dexcom CGM

The need to look beyond BMI

Heart failure, chronic kidney disease and diabetes: Improving outcomes with non-steroidal MRAs

Obesity management in the spotlight: how can we achieve patient-centricity? ​

Embracing innovation in a new era of diabetes care: A CME Symposium

From Burden to Breakthrough: Reimagining Type 1 Diabetes Treatment With Cell-Based Approaches

Thursday

Addressing the needs of all people living with type 1 diabetes

AI-based glucose predictions – bringing diabetes self-management to the next level

Breaking the barriers: Addressing the metabolic impact of MASH with multidisciplinary care

Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies 

Cholesterol Lowering in High Cardiovascular Risk Patients with Comorbidities: Closing Gaps and Future Opportunities

Management of CKD in T2D – where are we today?

Friday

Multidisciplinary dialogue on non-invasive liver assessment in patients with obesity: from guidelines to clinical research

Enabling women with type 1 diabetes to achieve their goals with Automated Insulin Delivery